MORE►
Astromech
Ben Lamm is co-founder of Astromech. [Photo: Astromech]
Astromech Raises $20M for Next Phase of Bringing AI to Evolutionary Biology
by Lauren Lawley Head | Aug 20, 2026
The Dallas-based Colossal Biosciences spinout, now valued at $3.8 billion, is preparing forecasting pilots in health and biosecurity as it scales the model behind its predictions.
by Quincy Preston |
Apr 30, 2026
At a $10 billion valuation—and spinning out new ventures—Colossal names the bluebuck its sixth de-extinction target, extending its biotech platform into antelope conservation through a global BioVault effort.
MORE►
